London CO Of Virginia Bristol Myers Squibb CO Transaction History

London CO Of Virginia

$18.6 Billion
Q3 2024

A detailed history of London CO Of Virginia transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, London CO Of Virginia holds 51,206 shares of BMY stock, worth $2.96 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

51,206

Previous 73,092 29.94%

Holding current value

$2.96 Million

Previous $3.04 Million 12.72%

% of portfolio

0.01%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $867,998 - $1.13 Million	-21,886 Reduced 29.94%	51,206 $2.65 Million
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $440,657 - $580,134	-10,948 Reduced 13.03%	73,092 $3.04 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $171,000 - $193,881	3,564 Added 4.43%	84,040 $4.56 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $183,060 - $218,441	-3,776 Reduced 4.48%	80,476 $4.13 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $1.25 Million - $1.4 Million	-21,660 Reduced 20.45%	84,252 $4.89 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $37,397 - $41,524	-587 Reduced 0.55%	105,912 $6.77 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $387,491 - $439,503	-5,897 Reduced 5.25%	106,499 $7.38 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $467 - $276,393	-3,597 Reduced 3.1%	112,396 $7.99 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $107,768 - $118,690	-1,484 Reduced 1.26%	115,993 $8.93 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $9,959 - $11,942	-162 Reduced 0.14%	117,477 $8.58 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $4.45 Million - $5.19 Million	-82,954 Reduced 41.35%	117,639 $7.34 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $29.1 Million - $34.1 Million	-492,593 Reduced 71.06%	200,593 $11.9 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $469,153 - $510,908	7,578 Added 1.11%	693,186 $46.3 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $314,798 - $354,055	5,305 Added 0.78%	685,608 $43.3 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $312,604 - $354,238	5,414 Added 0.8%	680,303 $42.2 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $389,834 - $431,988	-6,788 Reduced 1.0%	674,889 $40.7 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $180,412 - $210,920	3,291 Added 0.49%	681,677 $40.1 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $186,667 - $271,270	4,023 Added 0.6%	678,386 $37.8 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $1 Million - $1.31 Million	-20,413 Reduced 2.94%	674,363 $43.3 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $1.31 Million - $1.56 Million	-30,733 Reduced 4.24%	694,776 $35.2 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $6.93 Million - $7.67 Million	-155,407 Reduced 17.64%	725,509 $32.9 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $286,602 - $341,737	6,352 Added 0.73%	880,916 $42 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $2.34 Million - $3.03 Million	-47,891 Reduced 5.19%	874,564 $45.5 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $1.76 Million - $1.98 Million	-31,837 Reduced 3.34%	922,455 $57.3 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $2.29 Million - $2.85 Million	-45,315 Reduced 4.53%	954,292 $52.8 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $116,484 - $134,097	-1,944 Reduced 0.19%	999,607 $63.2 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $1.13 Million - $1.24 Million	-18,925 Reduced 1.85%	1,001,551 $61.4 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $56.4 Million - $65 Million	1,020,476	1,020,476 $65 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of London CO Of Virginia, based on Form 13F filings with the SEC.

News

Stay updated on London CO Of Virginia with notifications on news.

Account

London CO Of Virginia Bristol Myers Squibb CO Transaction History